Applied DNA Company Leadership
| APDN Stock | USD 4.78 1.02 17.59% |
Applied DNA's insiders are aggressively buying. The analysis of insiders' sentiment of trading Applied DNA Sciences stock suggests that virtually all insiders are extremely bullish at this time. Applied DNA employs about 52 people. The company is managed by 24 executives with a total tenure of roughly 148 years, averaging almost 6.0 years of service per executive, having 2.17 employees per reported executive.
| James Hayward Chairman Chairman of the Board and Presidentident, CEO |
Applied DNA's Insider Buying Vs Selling
100
Selling | Buying |
Latest Trades
| 2020-06-26 | William W Montgomery | Acquired 110000 @ 5.25 | View | ||
| 2020-06-18 | William W Montgomery | Acquired 40000 @ 5.25 | View | ||
| 2020-06-09 | William W Montgomery | Acquired 75000 @ 5.25 | View | ||
| 2019-11-13 | William W. Montgomery | Acquired 75000 @ 5.24 | View | ||
| 2019-09-16 | William W Montgomery | Acquired 6678 @ 0.36 | View | ||
| 2019-08-22 | William W Montgomery | Acquired 400000 @ 0.27 | View | ||
| 2019-01-24 | William W Montgomery | Acquired 50000 @ 0.47 | View | ||
| 2019-01-22 | William W Montgomery | Acquired 60000 @ 0.44 | View | ||
| 2019-01-18 | William W Montgomery | Acquired 100000 @ 0.44 | View | ||
| 2019-01-07 | William W Montgomery | Acquired 400000 @ 0.45 | View | ||
| 2019-01-03 | William W Montgomery | Acquired 154000 @ 0.44 | View | ||
| 2018-12-31 | William W Montgomery | Acquired 30000 @ 0.37 | View | ||
| 2014-11-20 | James A Hayward | Acquired 76923 @ 3.24 | View |
Monitoring Applied DNA's insider sentiment can offer insights into its future performance, as insiders often have access to more information about their company's operations, financial health, and upcoming initiatives than the general public. However, it's essential to note that insider trading is regulated by securities laws, and insiders are required to disclose their trades publicly to ensure transparency and prevent unfair advantages based on non-public information.
Applied |
Applied DNA Management Team Effectiveness
The company has return on total asset (ROA) of (0.5596) % which means that it has lost $0.5596 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (1.1002) %, meaning that it created substantial loss on money invested by shareholders. Applied DNA's management efficiency ratios could be used to measure how well Applied DNA manages its routine affairs as well as how well it operates its assets and liabilities. As of the 24th of April 2024, Return On Tangible Assets is likely to drop to -66.75. In addition to that, Return On Capital Employed is likely to grow to -60.39. At this time, Applied DNA's Asset Turnover is very stable compared to the past year.As of the 24th of April 2024, Common Stock Shares Outstanding is likely to grow to about 15.8 M, while Net Loss is likely to drop (10.1 M).
Applied DNA Workforce Comparison
Applied DNA Sciences is number one stock in number of employees category among related companies. The total workforce of Information Technology industry is presently estimated at about 2,003. Applied DNA holds roughly 52.0 in number of employees claiming about 2.6% of equities under Information Technology industry.
Applied DNA Profit Margins
The company has Profit Margin (PM) of (0.8) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (4.25) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $4.25.| Current Value | Last Year | Change From Last Year | 10 Year Trend | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Gross Profit Margin | 0.72 | 0.48 |
|
|
Applied DNA Insider Trading
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Applied DNA insiders, such as employees or executives, is commonly permitted as long as it does not rely on Applied DNA's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases, Applied DNA insiders must file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Judith Murrah over a month ago Acquisition by Judith Murrah of 150000 shares of Applied DNA subject to Rule 16b-3 | ||
Yacov Shamash over two months ago Applied DNA exotic insider transaction detected | ||
Schmalz Elizabeth M over a year ago Acquisition by Schmalz Elizabeth M of 75099 shares of Applied DNA subject to Rule 16b-3 |
Applied DNA Notable Stakeholders
An Applied DNA stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Applied DNA often face trade-offs trying to please all of them. Applied DNA's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Applied DNA's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
| James Hayward | Chairman of the Board and Presidentident, CEO | Profile | |
| ScD Hayward | President Chairman | Profile | |
| Beth Jantzen | CFO | Profile | |
| Judith Murrah | Chief COO | Profile | |
| Sanford Simon | Director and Member of Nominating Committee | Profile | |
| Robert Catell | Director | Profile | |
| John Bitzer | Independent Director | Profile | |
| Yacov Shamash | Independent Director | Profile | |
| Elizabeth Ferguson | Director | Profile | |
| Joseph Ceccoli | Director | Profile | |
| Charles Ryan | Independent Director | Profile | |
| CPA CPA | Chief Officer | Profile | |
| Warren Pearlson | Sales Consultant | Profile | |
| MingHwa Liang | Secretary, Strategic Technology Development Officer | Profile | |
| Tony Benson | Managing EMEA | Profile | |
| Janice Meraglia | G VP | Profile | |
| JD Esq | Chief Development | Profile | |
| Joseph Magno | Sales Consultant | Profile | |
| MeiLin Wan | VP Sales | Profile | |
| John Shearman | Ex Bus | Profile | |
| Beth CPA | Chief Officer | Profile | |
| Karol Gray | Financial Consultant | Profile | |
| Sanjay Hurry | Executive Communications | Profile | |
| Stephen Hughes | Director Programs | Profile |
About Applied DNA Management Performance
The success or failure of an entity such as Applied DNA Sciences often depends on how effective the management is. Applied DNA management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Applied management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Applied management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | (63.57) | (66.75) | |
| Return On Capital Employed | (63.57) | (60.39) | |
| Return On Assets | (63.57) | (60.39) | |
| Return On Equity | (63.57) | (60.39) |
The data published in Applied DNA's official financial statements usually reflect Applied DNA's business processes, product offerings, services, and other fundamental events. But there are other numbers, ratios, or fundamental indicators derived from these statements that are easier to understand and visualize within the underlying realities that drive quantitative information of Applied DNA Sciences. For example, before you start analyzing numbers published by Applied accountants, it's critical to develop an understanding of what Applied DNA's liquidity, profitability, and earnings quality are in the context of the Electronic Equipment, Instruments & Components space in which it operates.
Please note, the presentation of Applied DNA's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Applied DNA's management is honest, while the outside auditors are strict and uncompromising. Whatever the case, the imprecision that can be found in Applied DNA's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Applied DNA Sciences. Please utilize our Beneish M Score to check the likelihood of Applied DNA's management manipulating its earnings.
Applied DNA Workforce Analysis
Traditionally, organizations such as Applied DNA use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Applied DNA within its industry.Applied DNA Manpower Efficiency
Return on Applied DNA Manpower
| Revenue Per Employee | 257.1K | |
| Revenue Per Executive | 557K | |
| Net Loss Per Employee | 192.7K | |
| Net Loss Per Executive | 417.6K | |
| Working Capital Per Employee | 101.6K | |
| Working Capital Per Executive | 220K |
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Applied DNA Sciences. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in unemployment. Note that the Applied DNA Sciences information on this page should be used as a complementary analysis to other Applied DNA's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Pair Correlation module to compare performance and examine fundamental relationship between any two equity instruments.
Complementary Tools for Applied Stock analysis
When running Applied DNA's price analysis, check to measure Applied DNA's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Applied DNA is operating at the current time. Most of Applied DNA's value examination focuses on studying past and present price action to predict the probability of Applied DNA's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Applied DNA's price. Additionally, you may evaluate how the addition of Applied DNA to your portfolios can decrease your overall portfolio volatility.
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Stocks Directory Find actively traded stocks across global markets | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume |
Is Applied DNA's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Applied DNA. If investors know Applied will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Applied DNA listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.55) | Revenue Per Share 0.678 | Quarterly Revenue Growth (0.83) | Return On Assets (0.56) | Return On Equity (1.10) |
The market value of Applied DNA Sciences is measured differently than its book value, which is the value of Applied that is recorded on the company's balance sheet. Investors also form their own opinion of Applied DNA's value that differs from its market value or its book value, called intrinsic value, which is Applied DNA's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Applied DNA's market value can be influenced by many factors that don't directly affect Applied DNA's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Applied DNA's value and its price as these two are different measures arrived at by different means. Investors typically determine if Applied DNA is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Applied DNA's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.